HLF HERBALIFE LTD.

FY2025 10-K
Filed: Feb 18, 2026
Consumer Staples
Wholesale-Drugs, Proprietaries & Druggists' SundriesSEC EDGAR

HERBALIFE LTD. (HLF) filed its fiscal year 2025 10-K annual report with the SEC on Feb 18, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business: Global health and wellness company using direct-selling model with independent Members distributing nutrition and lifestyle products in 95 markets
  • New products: Launched HL/Skin skincare line in Europe/Africa, Protein Gelato in Brazil, MultiBurn metabolic supplement and Life I/O™ healthy lifespan brand in North America
+3 more insights

Management Discussion & Analysis

  • Revenue $5,037.5M, up 0.9% YoY (+$44.4M); local currency sales up 2.5%
  • Operating margin 9.6% in 2025 vs 7.7% in 2024; net income $228.3M, down 10.2% YoY due to $132.2M higher income taxes
+3 more insights

Risk Factors

  • Regulatory risk: Compliance with FTC Consent Order, failure could materially harm business and financial results
  • Geopolitical risk: China market requires modified business model amid political and legal uncertainties
+3 more insights

Financial Summary
XBRL

Revenue

$5.0B

Net Income

$228M

Gross Margin

77.9%

Operating Margin

9.5%

Net Margin

4.5%

ROE

-44.3%

Total Assets

$2.8B

EPS (Diluted)

$2.20

Operating Cash Flow

$333M

Source: XBRL data from HERBALIFE LTD. FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on HERBALIFE LTD.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available